Cancer and neoplasms

Futibatinib by Otsuka Pharmaceutical for Metastatic Breast Cancer: Likelihood of Approval

Posted on by yun
27
Oct

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Futibatinib overview Futibatinib (Lytgobi) is an anticancer agent. It is formulated […]

Continue reading →
Blood

Blood-Based Biomarker Panel Aids Bipolar Disorder Diagnosis

Posted on by yun
27
Oct

Researchers at the University of Cambridge have developed a way of improving diagnosis of bipolar disorder (BD), which uses a simple dried blood spot (DBS) test to identify biomarkers associated with the condition. While the team’s newly reported study suggested that the blood test on its own could diagnose up to 30% of patients with bipolar disorder, their […]

Continue reading →
Infection

Study reveals new treatment option for recurrent urinary tract infections

Posted on by yun
27
Oct

MIRAMAR, Fla. – According to a study published in the Journal of Obstetrics and Gynecology, vaginal estrogen is effective in treating UTI’s in women with lower than normal levels of estrogen. Dr. Jonathan Black with the Center for Gynecologic Oncology said that happens in older women as a result of menopause but can also affect […]

Continue reading →
Infection

Vibrio cases, deaths in Florida doubled after Hurricane Ian

Posted on by yun
27
Oct

October 27, 2023 3 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]

Continue reading →
Infection

COVID Upended Bronchiolitis Admission Patterns in Kids

Posted on by yun
27
Oct

Pediatric bronchiolitis hospitalizations took a brief downturn during the pandemic before consistently rising thereafter, with seasonal patterns yet to return to normal, a nationwide study found. After admissions plummeted by 69.2% in the 2020-2021 season, the subsequent 2022-2023 season tracked at 75.3% above the pre-pandemic median. Patients who were ages 12 to 23 months saw […]

Continue reading →
Cardiovascular

High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study

Posted on by yun
27
Oct

Baseline characteristics stratified by the occurrence of the primary endpoint A total of 4530 patients with coronary bifurcation lesions were included in final analysis (Fig. 1). the distribution of the TyG index was depicted in additional file 1: Fig. S1. Baseline characteristics of patients with and without CV events are shown in Table 1. Patients experiencing CV […]

Continue reading →
Cardiovascular

Predictive value of the stress hyperglycemia ratio in dialysis patients with acute coronary syndrome: insights from a multi-center observational study

Posted on by yun
27
Oct

Study design and population The present study employed data obtained from the CRUISE-R (Coronary Revascularization in Patients On Dialysis in China-Retrospective) cohort study (ClinicalTrials.gov NCT05841082). The CRUISE-R study sought to undertake a comprehensive, observational, and multi-center registry investigation in China, targeting dialysis patients who were afflicted with coronary artery disease. The study’s principal objectives were […]

Continue reading →
Cardiovascular

Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study

Posted on by yun
27
Oct

Baseline characteristics The ACCORD study enrolled 10,251 participants, of which 5,128 were randomized to achieve a target glycated hemoglobin level < 6·0% (intensive treatment group). We excluded 199 participants whose HVS could not be calculated. Hence, our post-hoc analysis included 10,052 participants. The mean age of the participants was 62·7 years (SD 6·62), and 6,196 (61·6%) of […]

Continue reading →